Helix Acquisition CORP Ii DEF 14A proxy statements
Proxy statements, covering the matters put to shareholders at the annual meeting — board elections, auditor ratification and executive pay.
BridgeBio Oncology Therapeutics, Inc. announced its 2026 Annual Meeting of Stockholders, scheduled for June 16, 2026, to elect directors and ratify auditor appointments.